Inventor
BUONAMICI SILVIA
US11 patents
⚠️ This page may combine multiple inventors who share the name “BUONAMICI SILVIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EISAI R&D MAN CO LTD
10 patentsUS9481669B2Nov 1, 2016
Pladienolide pyridine compounds and methods of use
EISAI R&D MAN CO LTD7 citations81
US11352348B2Jun 7, 2022
Splicing modulator antibody-drug conjugates and methods of use
EISAI R&D MAN CO LTD1 citations71
US10889866B2Jan 12, 2021
Splice variants associated with neomorphic SF3B1 mutants
EISAI R&D MAN CO LTD2 citations68
US12514926B2Jan 6, 2026
Splicing modulator antibody-drug conjugates and methods of use
EISAI R&D MAN CO LTD0 citations60
US12172986B2Dec 24, 2024
Splicing modulator antibody-drug conjugates and methods of use
EISAI R&D MAN CO LTD0 citations60
US11945807B2Apr 2, 2024
Splicing modulator antibody-drug conjugates and methods of use
EISAI R&D MAN CO LTD0 citations60
US11998544B2Jun 4, 2024
Methods of using splicing modulators
EISAI R&D MAN CO LTD0 citations59
US11761045B2Sep 19, 2023
Splice variants associated with neomorphic SF3B1 mutants
EISAI R&D MAN CO LTD0 citations57
US11524009B2Dec 13, 2022
Combination comprising at least one spliceosome modulator and at least one inhibitor chosen from BCL2 inhibitors, BCL2/BCLxL inhibitors, and BCLxL inhibitors and methods of use
EISAI R&D MAN CO LTD0 citations55
US10745387B2Aug 18, 2020
Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereof
EISAI R&D MAN CO LTD0 citations49